Caxton as of Dec. 31, 2016
Portfolio Holdings for Caxton
Caxton holds 12 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Strongbridge Bioph shs usd | 44.2 | $13M | 5.4M | 2.40 | |
| Agile Therapeutics | 41.3 | $12M | 2.1M | 5.70 | |
| Berkshire Hathaway (BRK.B) | 5.0 | $1.5M | 8.9k | 163.00 | |
| Garrison Capital | 1.7 | $487k | 52k | 9.34 | |
| Cm Fin | 1.4 | $398k | 43k | 9.31 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $359k | 13k | 27.11 | |
| Paratek Pharmaceuticals | 1.1 | $338k | 22k | 15.42 | |
| Team Health Holdings | 1.1 | $328k | 7.5k | 43.46 | |
| Adient (ADNT) | 0.9 | $278k | 4.7k | 58.69 | |
| American Cap Sr Floating | 0.7 | $213k | 18k | 11.88 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.7 | $212k | 20k | 10.41 | |
| Stellus Capital Investment (SCM) | 0.6 | $188k | 16k | 12.06 |
